KEYNOTE-355 Final Results
KEYNOTE-355: Randomized, Placebo-Controlled Phase III of Pembrolizumab + Chemotherapy in Previously Untreated Metastatic TNBC (Final Results)

Released: September 28, 2021

Activity

Progress
1
Course Completed